Atlas Trials

Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy

Clinical trial NCT00188383 · UNKNOWN

Trial details

NCT number
NCT00188383
Sponsor
University Health Network, Toronto
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
HyperalgesiaPainProstate Cancer
Start date
2004-01-01
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.